Point72 »

Aclaris Therapeutics shares owned by Point72

Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by Point72 from 13F filings

Historical chart of Point72 investment in Aclaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aclaris Therapeutics held by Point72 consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aclaris Therapeutics by Point72

Quarter filed Position value Share count Share price at filing
2024-09-30 $106 92 1.15
2024-06-30 $20k 18k 1.10

More positions owned by Point72

Spdr Dow Jones Indl Average Ut Ser 1 Call Option (DIA)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Broadcom Call Option (AVGO)
Cisco Systems Call Option (CSCO)
Nike CL B Call Option (NKE)
Deere & Company Call Option (DE)
Adobe Systems Incorporated (ADBE)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Bristol Myers Squibb Call Option (BMY)
Accenture Plc Ireland Shs Class A Call Option (ACN)
NVIDIA Corporation Call Option (NVDA)
McKesson Corporation (MCK)
Bruker Corporation (BRKR)
General Motors Company (GM)

View all positions for Point72

Top funds holding Aclaris Therapeutics

BML Capital Management
Vanguard Group
D. E. Shaw & Co
Rock Springs Capital Management
Stonepine Capital Management
Acadian Asset Management
BlackRock
Trium Capital
BlackRock
Two Sigma Advisers
Renaissance Technologies
Two Sigma Investments
Aldebaran Capital
Bain Capital Life Sciences Investors
Qube Research & Technologies

View all funds holding Aclaris Therapeutics